Dr. rer. nat. Andreas Puyskens is an immunologist and researcher based in Berlin, Germany. Member of the Global Virus Network (GVN) and nominated qualified expert for the UN Secretary-General’s Mechanism for Investigation of Alleged Use of Chemical or Biological Weapons (UNSGM).

ORCID
PubMed
LinkedIn
ResearchGate
Instagram

Upcoming conference engagements:
Medical Biodefense Conference 2025 – 07.04.-10-04.2025

International projects:
2023 – ongoing: Global Health Protection Programme (GHPP): IDEAnet: Network for the Identification of Emerging Agents in Sri Lanka
2021-2022: Global Health Protection Programme (GHPP): IDEA: Identification of Emerging Agents. Strengthening Diagnostic Capacities for the Detection of Infectious Diseases in Sri Lank
2022: German Biosecurity Programme. Biosafety training in Tunisia
2021: German Biosecurity Programme. Laboratory assessments and trainings in Sudan
2021: German Epidemic Preparedness Team (SEEG). Aid SARS-CoV-2 response in Mauretania

Active Networks:
Global Virus Network (GVN)

Publications:
2023: Results of German external quality assessment schemes for SARS-CoV-2 antigen detection (Scientific Reports)
2023: Flexible upscaling of laboratory PCR testing capacity at the Robert Koch Institute during the SARS-CoV-2 pandemic (Virology Journal)
2023: Direct comparison of clinical diagnostic sensitivity of saliva from buccal swabs versus combined oro-/nasopharyngeal swabs in the detection of SARS-CoV-2 B.1.1.529 Omicron (Journal of Clinical Virology)
2023: Performance of 20 rapid antigen detection tests to detect SARS-CoV-2 B.1.617.2 (Delta) and B.1.1.529 (Omicron) variants using a clinical specimen panel from January 2022, Berlin, Germany (Eurosurveillance)
2022: Canine real-time detection of SARS-CoV-2 infections in the context of a mass screening event (BMJ Global Health)
2021: Discrimination of SARS-CoV-2 Infections From Other Viral Respiratory Infections by Scent Detection Dogs (Frontiers in Medicine)
2021: Establishment of a specimen panel for the decentralised technical evaluation of the sensitivity of 31 rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021 (Eurosurveillance)
2021: Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021 (Eurosurveillance)
2021: Resource-efficient internally controlled in-house real-time PCR detection of SARS-CoV-2 (Virology Journal)
2021: Sensitive on-site detection of SARS-CoV-2 by ID NOW COVID-19 (Molecular and Cellular Probes)
2020: Aryl Hydrocarbon Receptor Modulation by Tuberculosis Drugs Impairs Host Defense and Treatment Outcomes (Cell Host & Microbe)
2019: Host monitoring of quorum sensing during Pseudomonas aeruginosa infection (Science)
2019: The Henna pigment Lawsone activates the Aryl Hydrocarbon Receptor and impacts skin homeostasis (Scientific Reports)
2017: Distribution and Activation of CD8+ T Cells in the Duodenal Mucosa before and after HIV Seroconversion (Journal of Immunology)
2015: RP105 Engages Phosphatidylinositol 3-Kinase p110δ To Facilitate the Trafficking and Secretion of Cytokines in Macrophages during Mycobacterial Infection (Journal of Immunology)

Interviews:
Bei Mir Zuhause Podcast (2020)